M&T Bank’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Sell
13,120
-99
-0.7% -$8.68K ﹤0.01% 849
2026
Q1
$1.2M Sell
13,219
-11,968
-48% -$1.1M ﹤0.01% 770
2025
Q4
$2.26M Buy
25,187
+2,590
+11% +$246K 0.01% 594
2025
Q3
$2.23M Sell
22,597
-1,784
-7% -$177K 0.01% 565
2025
Q2
$2.22M Sell
24,381
-1,434
-6% -$139K 0.01% 587
2025
Q1
$2.92M Sell
25,815
-1,012
-4% -$108K 0.01% 500
2024
Q4
$2.83M Buy
26,827
+108
+0.4% +$11.6K 0.01% 561
2024
Q3
$2.88M Buy
26,719
+8,709
+48% +$950K 0.01% 561
2024
Q2
$1.95M Sell
18,010
-295
-2% -$34.8K 0.01% 661
2024
Q1
$2.42M Sell
18,305
-492
-3% -$61.5K 0.01% 588
2023
Q4
$2.29M Sell
18,797
-719
-4% -$80.2K 0.01% 590
2023
Q3
$2.19M Sell
19,516
-5,003
-20% -$635K 0.01% 584
2023
Q2
$3.57M Sell
24,519
-2,299
-9% -$312K 0.01% 485
2023
Q1
$3.47M Buy
26,818
+863
+3% +$108K 0.01% 486
2022
Q4
$3.31M Sell
25,955
-2,486
-9% -$288K 0.01% 485
2022
Q3
$2.97M Sell
28,441
-1,224
-4% -$134K 0.01% 486
2022
Q2
$2.37M Buy
29,665
+7,415
+33% +$880K 0.01% 518
2022
Q1
$2.85M Sell
22,250
-3,734
-14% -$450K 0.01% 470
2021
Q4
$3.21M Sell
25,984
-11,122
-30% -$1.46M 0.01% 458
2021
Q3
$5.27M Buy
37,106
+268
+0.7% +$39.4K 0.02% 364
2021
Q2
$5.75M Buy
36,838
+1,128
+3% +$183K 0.03% 350
2021
Q1
$5.55M Buy
35,710
+4,387
+14% +$680K 0.02% 354
2020
Q4
$4.69M Buy
31,323
+1,059
+3% +$150K 0.02% 383
2020
Q3
$4M Buy
30,264
+415
+1% +$54.2K 0.02% 381
2020
Q2
$3.46M Sell
29,849
-3,102
-9% -$357K 0.02% 397
2020
Q1
$3.23M Sell
32,951
-2,237
-6% -$293K 0.02% 407
2019
Q4
$5.11M Buy
35,188
+380
+1% +$52.5K 0.02% 277
2019
Q3
$4.64M Sell
34,808
-307
-0.9% -$39.7K 0.02% 336
2019
Q2
$4.01M Sell
35,115
-840
-2% -$98.4K 0.02% 369
2019
Q1
$4.46M Buy
35,955
+1,923
+6% +$219K 0.02% 342
2018
Q4
$3.43M Sell
34,032
-13,521
-28% -$1.52M 0.02% 371
2018
Q3
$6.07M Buy
47,553
+418
+0.9% +$49.7K 0.03% 313
2018
Q2
$5.1M Sell
47,135
-220
-0.5% -$23.9K 0.03% 347
2018
Q1
$5.01M Sell
47,355
-259
-0.5% -$30.1K 0.03% 350
2017
Q4
$5.58M Sell
47,614
-5,383
-10% -$609K 0.03% 333
2017
Q3
$6.02M Sell
52,997
-3,647
-6% -$421K 0.03% 313
2017
Q2
$7.06M Sell
56,644
-3,104
-5% -$368K 0.04% 293
2017
Q1
$7.08M Buy
59,748
+131
+0.2% +$14.8K 0.04% 273
2016
Q4
$5.97M Buy
59,617
+5,530
+10% +$593K 0.04% 293
2016
Q3
$6.83M Sell
54,087
-3,119
-5% -$385K 0.04% 264
2016
Q2
$6.69M Sell
57,206
-6,949
-11% -$786K 0.05% 276
2016
Q1
$6.64M Sell
64,155
-7,043
-10% -$681K 0.05% 280
2015
Q4
$7.09M Buy
71,198
+3,498
+5% +$342K 0.05% 267
2015
Q3
$6.17M Buy
67,700
+9,202
+16% +$922K 0.04% 289
2015
Q2
$6.2M Buy
58,498
+1,860
+3% +$206K 0.04% 304
2015
Q1
$6.46M Sell
56,638
-734
-1% -$83.7K 0.04% 316
2014
Q4
$6.32M Sell
57,372
-1,952
-3% -$206K 0.04% 327
2014
Q3
$5.79M Buy
59,324
+38,536
+185% +$3.79M 0.04% 340
2014
Q2
$2.1M Sell
20,788
-50
-0.2% -$4.88K 0.09% 169
2014
Q1
$1.91M Sell
20,838
-261
-1% -$24.1K 0.08% 174
2013
Q4
$1.91M Buy
21,099
+9,617
+84% +$832K 0.08% 170
2013
Q3
$915K Sell
11,482
-438
-4% -$34.5K 0.04% 260
2013
Q2
$868K Buy
+11,920
New +$891K 0.04% 271

Other funds holding ZBH

M&T Bank's ZBH Position: Q2 2026 in Review

M&T Bank reduced its Zimmer Biomet (ZBH) stake by 0.75% in Q2 2026, selling an estimated $8.68K and leaving 13,120 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #849.

M&T Bank first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.09M in Q4 2015. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • M&T Bank held 13,120 shares of Zimmer Biomet worth $1.13M as of Q2 2026.
  • M&T Bank sold 99 Zimmer Biomet shares in Q2 2026, an estimated $8.68K.
  • Zimmer Biomet made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #849 holding.
  • M&T Bank first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
  • M&T Bank's Zimmer Biomet position peaked at $7.09M in Q4 2015.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.